Skip to product information
1 of 1

Prolactin R/PRLR Fc Chimera Protein, Human

Prolactin R/PRLR Fc Chimera Protein, Human

Catalog Number: UA016068 Brand: UA BIOSCIENCE
Price:
Regular price $215 USD
Regular price Sale price $215 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Prolactin receptor, PRL-R
Accession P16471
Amino Acid Sequence

Gln25-Asp234 with hIgG1 Fc Tag at the C-Terminus

Expression System HEK293
Molecular Weight 55-70kDa (Reducing)
Purity >90% by SDS-PAGE,> 80% by HPLC
Conjugation Unconjugated
Tag Human IgG1 Fc
Physical Appearance Lyophilized powder
Storage Buffer

PBS, PH7.4, 5% trehalose

Reconstitution Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Stability & Storage

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.

Reference

1.Harris J, Stanford PM, Oakes SR, Ormandy CJ. Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med. 2004;36(6):414-25. 
2.Brooks CL. Molecular mechanisms of prolactin and its receptor. Endocr Rev. 2012 Aug;33(4):504-25. 

Background

Prolactin receptor (PRLR) is a member of the cytokine receptor superfamily, composed of an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular signaling domain, with three isoforms (long, short, and intermediate). Upon binding to prolactin, it activates the JAK2-STAT5 signaling pathway to regulate physiological processes including mammary gland development, lactation, metabolism, and immune modulation. Clinical studies have demonstrated that PRLR is highly expressed in various tumors such as breast and prostate cancers, promoting cancer cell proliferation, invasion, and drug resistance through autocrine/paracrine loops, making it an emerging therapeutic target for antitumor treatment, with monoclonal antibodies and small molecule antagonists currently under clinical development.

Picture

SDS-PAGE

2μg (R: reducing condition, N:non-reducing condition).

SEC-HPLC

The purity of Prolactin R/PRLR Fc Chimera Protein, Human is more than 80% determined by SEC-HPLC.

ELISA

Immobilized Human PRL, His tag (Cat. No. S0A0016) at 1.0μg/mL (100μL/well) can bind Prolactin R/PRLR Fc Chimera Protein, Human (Cat. No. UA016068) with EC50 of 4.11-7.47 ng/mL.